Pediatric Brain Research and Intervention Center, Institute for Juvenile Research, Berger-Colbeth Clinic, University of Illinois at Chicago, IL 60608, USA.
Behav Brain Res. 2012 Jan 15;226(2):493-503. doi: 10.1016/j.bbr.2011.10.003. Epub 2011 Oct 8.
The aim of the current study was to determine the influence of implicated affective circuitry disturbance in pediatric bipolar disorder (PBD) on behavioral inhibition. The differential influence of an antipsychotic and an anti-epileptic medication on the functional connectivity across affective and cognitive neural operations in PBD was examined.
This was a six-week double blind randomized fMRI trial of risperidone plus placebo vs. divalproex plus placebo for patients with mania (n=22; 13.6 ± 2.5 years). Healthy controls (HC; n=14, 14.5 ± 2.8 years) were also scanned for normative comparison. Participants performed a response inhibition fMRI task where a motor response, already 'on the way' to execution, had to be voluntarily inhibited on trials where a stop signal was presented. Independent component analysis was used to map functional connectivity across the whole brain.
While there were no behavioral differences between the groups at pre- or post-drug trial, there was significant improvement on manic symptoms in the patient groups. All participants engaged an evaluative affective circuit (EAC: bilateral inferior frontal gyrus, middle frontal gyrus, anterior cingulate cortex (ACC), middle temporal gyrus, insulae, caudate and putamen) and a reactive affective circuit (RAC: bilateral occipital cortex, amygdala, medial frontal gyrus and insula) during task performance. Within the EAC, post-treatment and relative to HC, greater engagement was seen in left insula in risperidone group and left subgenual ACC in divalproex group. Within the RAC, greater baseline amygdala connectivity in patients did not alter with treatment.
EAC and RAC are two key circuits that moderate emotional influence on response inhibition in PBD. Risperidone and divalproex differentially engage the EAC. Limited change in amygdala activity with treatment in all patients indicates a likely trait deficit in PBD.
本研究旨在探讨儿童双相障碍(PBD)中潜在情感回路紊乱对行为抑制的影响。研究考察了抗精神病药物和抗癫痫药物对 PBD 中情感和认知神经功能连接的影响。
这是一项为期 6 周的双盲随机 fMRI 试验,研究对象为接受利培酮加安慰剂或丙戊酸钠加安慰剂治疗的躁狂患者(n=22;13.6±2.5 岁)。还对健康对照组(HC;n=14,14.5±2.8 岁)进行了扫描,以进行正常比较。参与者执行反应抑制 fMRI 任务,即在出现停止信号时,需要主动抑制已经“进行中”的运动反应。独立成分分析用于绘制整个大脑的功能连接图。
尽管两组在药物治疗前或后均无行为差异,但患者组的躁狂症状有明显改善。所有参与者在任务执行过程中都参与了一个评估性情感回路(EAC:双侧额下回、额中回、前扣带回皮层(ACC)、颞中回、岛叶、尾状核和壳核)和一个反应性情感回路(RAC:双侧枕叶皮层、杏仁核、额内侧回和岛叶)。在 EAC 中,与 HC 相比,利培酮组的左侧岛叶和丙戊酸钠组的左侧扣带回前回在治疗后有更高的参与度。在 RAC 中,患者的基线杏仁核连接度增加,但治疗后并未改变。
EAC 和 RAC 是调节 PBD 中情绪对反应抑制影响的两个关键回路。利培酮和丙戊酸钠对 EAC 的影响不同。所有患者的杏仁核活动在治疗后没有变化,这表明 PBD 可能存在潜在的特征缺陷。